Table 1 Clinical characteristics of patients

From: PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

 

Melanoma ( n =18)

NSCLC ( n =8)

Age

  

 Median (range)

71 (45−87)

64 (52−77)

Gender

  

 Male/female

12/6

5/3

ECOG PS

  

 0/1−2

10/8

5/3

Tumour type

  

 Squamous/adenocarcinoma

 

1/7

BRAF mutation

  

 Yes/no

5/13

 

EGFR mutation

  

 Yes/no

 

1/7

ALK translocation

  

 Yes/no

 

0/8

First line immunotherapy

11/18

0/8

  1. Abbreviations: ALK=anaplastic lymphoma kinase; BRAF=v-RAF murine sarcoma viral oncogene homolog B1; ECOG PS=Eastern Cooperative Oncology Group performance status; EGFR=epidermal growth factor receptor; NSCLC=non-small cell lung cancer.
Back to article page